JP2014040393A5 - - Google Patents

Download PDF

Info

Publication number
JP2014040393A5
JP2014040393A5 JP2012183717A JP2012183717A JP2014040393A5 JP 2014040393 A5 JP2014040393 A5 JP 2014040393A5 JP 2012183717 A JP2012183717 A JP 2012183717A JP 2012183717 A JP2012183717 A JP 2012183717A JP 2014040393 A5 JP2014040393 A5 JP 2014040393A5
Authority
JP
Japan
Prior art keywords
gene
expression
aminoethanesulfonic acid
homologous
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012183717A
Other languages
Japanese (ja)
Other versions
JP2014040393A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2012183717A priority Critical patent/JP2014040393A/en
Priority claimed from JP2012183717A external-priority patent/JP2014040393A/en
Publication of JP2014040393A publication Critical patent/JP2014040393A/en
Publication of JP2014040393A5 publication Critical patent/JP2014040393A5/ja
Pending legal-status Critical Current

Links

Claims (3)

２−アミノエタンスルホン酸を含有することを特徴とする、表１に記載の遺伝子および／またはそのホモログ遺伝子の発現調節剤。 The expression regulator of the gene of Table 1 and / or its homologous gene characterized by containing 2-aminoethanesulfonic acid. ２−アミノエタンスルホン酸を有効成分として含有することを特徴とする、表１に記載の遺伝子および／またはそのホモログ遺伝子の発現変動を伴う疾患や症状の予防、診断、改善又は治療用製剤。 A preparation for preventing, diagnosing, improving or treating diseases and symptoms associated with fluctuations in the expression of the genes shown in Table 1 and / or homologous genes thereof, comprising 2-aminoethanesulfonic acid as an active ingredient. 表１に記載の遺伝子がＭＸＤ１、ＲＴＰ４又はＳＴＥＡＰ４である、請求項１又は２に記載の発現調節剤又は製剤。The expression regulator or preparation according to claim 1 or 2, wherein the gene shown in Table 1 is MXD1, RTP4, or STEAP4.
JP2012183717A 2012-08-23 2012-08-23 Gene expression regulating agent Pending JP2014040393A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012183717A JP2014040393A (en) 2012-08-23 2012-08-23 Gene expression regulating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012183717A JP2014040393A (en) 2012-08-23 2012-08-23 Gene expression regulating agent

Publications (2)

Publication Number Publication Date
JP2014040393A JP2014040393A (en) 2014-03-06
JP2014040393A5 true JP2014040393A5 (en) 2015-09-17

Family

ID=50392996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012183717A Pending JP2014040393A (en) 2012-08-23 2012-08-23 Gene expression regulating agent

Country Status (1)

Country Link
JP (1) JP2014040393A (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
JPH07238019A (en) * 1994-02-24 1995-09-12 Res Inst For Prod Dev Water-soluble taurine zinc compound
JPH08208464A (en) * 1994-12-02 1996-08-13 Taisho Pharmaceut Co Ltd Agent for treatment and prevention of hyperlipemia
JPH11246400A (en) * 1998-02-25 1999-09-14 Taisho Pharmaceut Co Ltd Protective agent against tissue damage caused by acrocinesia
JPH11279057A (en) * 1998-03-30 1999-10-12 Arimasa Miyamoto Ne kappa b activation inhibitor
JPH11343244A (en) * 1998-03-30 1999-12-14 Taisho Pharmaceut Co Ltd Oral composition
JP2001181183A (en) * 1999-10-19 2001-07-03 Taisho Pharmaceut Co Ltd Composition for increasing nk cell activity
JP5065570B2 (en) * 2002-09-06 2012-11-07 第一三共ヘルスケア株式会社 Vascular endothelial nitric oxide synthesis promoter
JP2004203863A (en) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd Antidiabetic composition
JP5830869B2 (en) * 2010-02-18 2015-12-09 大正製薬株式会社 Agents for improving visceral fat accumulation in obesity

Similar Documents

Publication Publication Date Title
DK3045456T3 (en) BICYCLICALLY SUBSTITUTED URACILES AND APPLICATION
JP2015526577A5 (en)
BR112016007562A2 (en) interference with repression of gene expression hd-zip transcription factor to produce plants with enhanced traits
MX2013011124A (en) Compounds for treatment of metabolic syndrome.
JP2014040393A5 (en)
TH113352B (en) chair
TH119977B (en) chair
TH119979B (en) chair
TH163163B (en) The variation in the lipid deposition of green algae and their use.
TH115705B (en) chair
TH118414B (en) chair
TH119979S (en) chair
TH45642S1 (en) chair
TH119977S (en) chair
TH113352S (en) chair
TH113351S (en) chair
TH45853S1 (en) chair
TH129576B (en) seat
TH120633B (en) Chair frame
TH120632B (en) Frame
TN2013000243A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
TH120628B (en) chair
TH120682B (en) chair
TH117287B (en) tank
TH45643S1 (en) chair